Polymeric nanoparticles-Promising carriers for cancer therapy

Area of Science:

• Nanotechnology
• Materials Science
• Oncology

Background:

• Polymeric nanoparticles (NPs) are crucial for controlled cancer drug delivery.
• Polymeric nanomedicine involves conjugating or encapsulating anticancer drugs into nanocarriers.
• Current systems show potential for sustained release, reduced cytotoxicity, and improved tumor retention.

Purpose of the Study:

• To review the current state of cancer drug-loading systems using polymeric NPs.
• To highlight the novelty and functions of various polymeric nanocarrier architectures.
• To identify contributions towards developing effective polymeric NPs for therapeutic purposes.

Main Methods:

• Literature review of published articles on cancer drug-loading systems.
• Analysis of different polymeric nanocarrier architectures.
• Evaluation of their functions and potential therapeutic applications.

Main Results:

• Identified various architectures: micelles, liposomes, dendrimers, polymersomes, hydrogels, and metal-organic frameworks.
• Highlighted the functions and novelty of these nanocarrier systems.
• Demonstrated the potential of polymeric NPs in cancer therapy.

Conclusions:

• Polymeric nanomedicine shows promise for improved cancer treatment outcomes.
• Despite progress, challenges remain in meeting clinical demands for drug delivery systems.
• Continued research into novel polymeric NP architectures is essential for advancing cancer therapy.